Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
Saved in:
| Main Authors: | Masaya Ono, Yoichi Sunagawa, Yasufumi Katanasaka, Koji Hasegawa, Tatsuya Morimoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-12-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2021.16.PO9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats
by: Yoichi Sunagawa, et al.
Published: (2021-12-01) -
The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
by: Mikuto Tojima, et al.
Published: (2021-12-01) -
Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
by: Yuto Kawase, et al.
Published: (2021-12-01) -
‘Donglin Zisheng’, a New Chrysanthemum morifolium Cultivar
by: Shengyan Chen, et al.
Published: (2025-02-01) -
USE OF INTERSPECIFIC HYBRIDIZATION IN THE BREEDING OF ADAPTIVE HYBRIDS AND SORTS OF GARDEN CHRYSANTHEMUM (Chrysanthemum morifolium Ramat.)
by: A. I. Nedoluzhko
Published: (2018-07-01)